v3.22.4
Consolidated Statements of Operations - USD ($)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Income Statement [Abstract]      
Sales, net of returns and allowances $ 5,023,072 $ (851,922) $ 1,392,519
Cost of sales 37,672,308 132,492,110 13,067,108
Gross loss (32,649,236) (133,344,032) (11,674,589)
Operating expenses      
Selling, general and administrative 73,220,088 40,160,795 20,157,658
Research and development 23,213,540 11,610,027 9,148,931
Total operating expenses 96,433,628 51,770,822 29,306,589
Loss from operations (129,082,864) (185,114,854) (40,981,178)
Interest expense, net 1,837,882 12,644,164 190,520,337
Other income (loss) 13,646,528 (225,432,884) 323,111,944
(Loss) income before (benefit) provision for income taxes (117,274,218) (423,191,902) 91,610,429
(Benefit) provision for income taxes 0 (21,847,089) 21,833,930
Net (loss) income $ (117,274,218) $ (401,344,813) $ 69,776,499
Net (loss) income attributable to common stockholders per share - basic (in usd per share) $ (0.74) $ (3.12) $ 0.75
Net (loss) income attributable to common stockholders per share - diluted (in usd per share) $ (0.74) $ (3.12) $ 0.70
Weighted average number of common shares outstanding - basic (in shares) 158,576,305 128,676,131 92,871,936
Weighted average number of common shares outstanding - diluted (in shares) 158,576,305 128,676,131 99,949,868

Source